The monkeypox vaccine will be applied in a new way to increase its yield
2022-08-10T12:56:23.103Z
The FDA gave emergency approval for the vaccine to be administered to high-risk adults intradermally instead of subcutaneously, as usual. The change will allow five doses to be obtained from a standard one-dose vial.